{"id":"W1974202914","doi":"10.2174/138161212799315975","title":"New Developments in Inhaled Antibiotics for the Treatment of Pseudomonas aeruginosa","year":2012,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Cystic fibrosis; Tobramycin; Pseudomonas aeruginosa; Antibiotics; Nebulizer; Medicine; Aerosolization; Pneumonia; Intensive care medicine; Lung disease; Lung; Inhalation; Microbiology; Bacteria; Internal medicine; Biology; Gentamicin; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006871665,0.0006987855,0.001044396,0.002261897,0.0002578864,0.0007406598,0.000541578,0.001073528,0.003026698],"category_scores_gemma":[0.0006207391,0.000265599,0.0006196104,0.001714663,0.0004450633,0.001332183,0.0005253905,0.002482007,0.002021614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003461838,"about_ca_system_score_gemma":0.0006690242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006237915,"about_ca_topic_score_gemma":0.001313753,"domain_scores_codex":[0.999686,0.00004413899,0.00005085776,0.00004647556,0.000151548,0.00002087799],"domain_scores_gemma":[0.9996203,0.0001941012,0.00006104206,0.00001170002,0.00008605143,0.00002686295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007692562,0.0001587629,0.0001585874,0.01520585,0.00005972826,0.0002893292,0.00009134673,0.0002702076,0.007227321,0.003012248,0.0127354,0.9607143],"study_design_scores_gemma":[0.00003884802,0.0003108558,0.001161219,0.003264301,0.0001133027,0.00258645,0.00006459784,0.0001120614,0.001769492,0.00168425,0.98887,0.00002465401],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001769175,0.9984217,0.000173922,0.000201363,0.0001605815,0.000005409979,0.000009412711,0.000006176817,0.000844576],"genre_scores_gemma":[0.0006423152,0.9980609,0.0003429429,0.0002109315,0.0001864706,0.000005616311,0.00001718265,0.000001428905,0.0005321916],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003026698,"threshold_uncertainty_score":0.01012528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3737254702533679,"score_gpt":0.5102760430366514,"score_spread":0.1365505727832835,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}